The pharmaceutical API industry in India is ranked third-largest globally in terms of volume. It is expected to clock a CAGR of 5-7% between fiscal 2023 and fiscal 2027, largely driven by the demand from domestic formulation manufacturers as well as export markets.
Cochin Shipyard shares tumble 8% as Q2 profit falls 50% YoY despite revenue growth
Cochin Shipyard shares fell sharply on Wednesday after the company reported a nearly 50% year-on-year decline in Q2 FY27 net profit to Rs 54 crore.